BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8899632)

  • 1. Transmitter packaging at frog neuromuscular junctions exposed to anticholinesterases; the role of second-stage acetylcholine loading.
    Naves LA; Van der Kloot W
    J Neurophysiol; 1996 Oct; 76(4):2614-25. PubMed ID: 8899632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoethylcholine as a false transmitter precursor at the frog and mouse neuromuscular junctions.
    Naves LA; Balezina OP; Van der Kloot W
    Brain Res; 1996 Aug; 730(1-2):58-66. PubMed ID: 8883889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repetitive nerve stimulation decreases the acetylcholine content of quanta at the frog neuromuscular junction.
    Naves LA; Van der Kloot W
    J Physiol; 2001 May; 532(Pt 3):637-47. PubMed ID: 11313435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine recycling and release at rat motor nerve terminals studied using (-)-vesamicol and troxpyrrolium.
    Searl T; Prior C; Marshall IG
    J Physiol; 1991 Dec; 444():99-116. PubMed ID: 1668355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing quantal size at the mouse neuromuscular junction and the role of choline.
    Yu SP; Van der Kloot W
    J Physiol; 1991 Feb; 433():677-704. PubMed ID: 1841963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic depression in frog neuromuscular junction.
    Glavinović MI
    J Neurophysiol; 1987 Jul; 58(1):230-46. PubMed ID: 2441003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The timing of channel opening during miniature endplate currents at the frog and mouse neuromuscular junctions: effects of fasciculin-2, other anti-cholinesterases and vesamicol.
    Van der Kloot W; Balezina OP; Molgó J; Naves LA
    Pflugers Arch; 1994 Sep; 428(2):114-26. PubMed ID: 7971167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The time course of miniature endplate currents and its modification by receptor blockade and ethanol.
    Linder TM; Pennefather P; Quastel DM
    J Gen Physiol; 1984 Mar; 83(3):435-68. PubMed ID: 6325590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting the rate of incorporation of a false transmitter into mammalian motor nerve terminals.
    Large WA; Rang HP
    J Physiol; 1978 Dec; 285():1-24. PubMed ID: 217983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of the action of a false transmitter at the neuromuscular junction.
    Colquhoun D; Large WA; Rang HP
    J Physiol; 1977 Apr; 266(2):361-95. PubMed ID: 192885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesicle size and transmitter release at the frog neuromuscular junction when quantal acetylcholine content is increased or decreased.
    Van der Kloot W; Molgó J; Cameron R; Colasante C
    J Physiol; 2002 Jun; 541(Pt 2):385-93. PubMed ID: 12042346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A further study of the neuromuscular effects of vesamicol (AH5183) and of its enantiomer specificity.
    Estrella D; Green KL; Prior C; Dempster J; Halliwell RF; Jacobs RS; Parsons SM; Parsons RL; Marshall IG
    Br J Pharmacol; 1988 Apr; 93(4):759-68. PubMed ID: 3260527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empty synaptic vesicles recycle and undergo exocytosis at vesamicol-treated motor nerve terminals.
    Parsons RL; Calupca MA; Merriam LA; Prior C
    J Neurophysiol; 1999 Jun; 81(6):2696-700. PubMed ID: 10368389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atypical miniature end plate currents in neuromuscular synapses of the rat under normal conditions, after acetylcholinesterase inhibition and cooling].
    Vinogradova IM; Krivoĭ II; Seĭ TP
    Biull Eksp Biol Med; 1990 Jun; 109(6):523-5. PubMed ID: 2397284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mobilization of the readily releasable pool of acetylcholine from a sympathetic ganglion by tityustoxin in the presence of vesamicol.
    Prado MA; Gomez MV; Collier B
    J Neurochem; 1992 Aug; 59(2):544-52. PubMed ID: 1629727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the properties of synaptic channels opened by acetylcholine in denervated frog muscle.
    Reiser G; Miledi R
    Brain Res; 1989 Feb; 479(1):83-97. PubMed ID: 2466537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of an inhibitor of the synaptic vesicle acetylcholine transport system on quantal neurotransmitter release: an electrophysiological study.
    Lupa MT
    Brain Res; 1988 Sep; 461(1):118-26. PubMed ID: 3265645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of transmitter quanta released during incorporation of a false transmitter into cholinergic nerve terminals.
    Large WA; Rang HP
    J Physiol; 1978 Dec; 285():25-34. PubMed ID: 217986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of vesamicol on trains of endplate currents and on focally recorded nerve terminal currents at mammalian neuromuscular junctions.
    Pemberton KE; Prior C; Marshall IG
    Br J Pharmacol; 1992 Jan; 105(1):113-8. PubMed ID: 1375854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of single quantal efficacy at the snake neuromuscular junction.
    Wilkinson RS; Lunin SD; Stevermer JJ
    J Physiol; 1992 Mar; 448():413-36. PubMed ID: 1350638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.